Back to News & Commentary

More news on the HPV vaccine

Rachel Hart,
Reproductive Freedom Project
Share This Page
February 9, 2006

The FDA has granted Merck Pharmaceuticals priority review for its HPV vaccine.

Let’s just hope that the controversy surrounding the vaccine doesn’t delay the approval process as it has with emergency contraception.

Learn More About the Issues on This Page